Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Cardinal Health’s profit margin lags behind peers, impacting growth. See why CAH stock’s outlook may be hindered by legal ...

Guided by McKesson's core belief that the patient comes first, McKesson Amplify is a strategic initiative intended to help protect critical pharmacy services and elevate the pharmacy profession by ...